We use our target mapping technology to develop imaging approaches that will guide the process of drug development. This imaging technology can detect and quantify the targets in the tissues. The quantitative mapping will help evaluate significance of the targets and the potential side-effects of the treatment against the targets, ensuring selection of right drug targets.
The imaging approaches that are validated in the development process will be translated to clinic for diagnosis and providing guidance for therapeutic treatment. The target mapping provides quantitative maps that record any changes to the targets. Thus, it can be used to stage diseases and identify the right patients to receive the appropriate treatments as well as following the treatment response.